Changes in plastic surgery training programs

March 3, 2015- Interviewed by Steven E. Greer, MD

In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez, MD, DDS, explains the changes in training programs now compared to 15-years ago.

The Weekly Summary

Chart All time highs in the marketFebruary 23rd – March 1st

In the general news, The Fed Chairwoman Yellen presented to congress and seemed to set the stage to raise interest rates this year, as the stock market hot all-time highs. The senate approved Loretta Lynch to be the Read more »

Interview with the CEO of Neovasc, Alexei Marko

Overview of rHGH therapy

January 14, 2015- Interviewed by Steven E. Greer, MD

We interviewed Dr. Shlomo Melmed, Director of the Clinical Research Institute and Dean of Faculty at Read more »

Current surgical weight loss therapies

January 24, 2014- Interviewed by Steven E. Greer, MD

Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band, and how the “sleeve” bypass is the main procedure of choice now for weight loss surgery.

Vaccinations that all adults should have

Interviewed by Steven E. Greer, MD

William Schaffner, MD, Professor and Chair of the Department of Preventive Medicine at Vanderbilt University School of Medicine, explains the six vaccinations that all adults should receive. They are: Read more »

Vagal nerve stimulation for weight loss

January 22, 2015- Interviewed by Steven E. Greer, MD

Erik Dutson, MD, bariatric surgeon from UCLA, Read more »

Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.

October 23, 2013- Interviewed by Steven E. Greer, MD

The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer. Topics discussed include the latest clinical trial data on inhaled insulin Afrezza and the cash situation. We also discuss Mr. Mann’s other company, Second Sight, which has a Medicare and FDA-approved bionic eye to treat diseases that damage the nerves in the retina.

Super rapid acting insulin and inhaled insulin

Interview with Dexcom’s CEO Terry Gregg

August 11, 2014- Interviewed by Steven E. Greer, MD

Above, in Part 1 of our interview with the CEO of Dexcom, Terry Gregg, Read more »

The 23andMe home genetics test kit controversy

Interviewed by Steven E. Greer, MD

In Part 1 of our interview with Robert Klitzman, MD, ethics professor at Columbia University, we discuss the 23andMe genetic test kit company and why the FDA made them stop marketing the tests.

WordPress Themes